• DRL launches Clofarabine injection in US market expressbpd
    November 15, 2017
    Dr Reddy’s Laboratories (DRL) has launched Clofarabine injection, a therapeutic equivalent generic version of Clolar (clofarabine) Injection in the US market, approved by the US Food & Drug Administration (US FDA).
PharmaSources Customer Service